Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the usefulness and safety of HD6610 granule for
oxaliplatin-induced peripheral neuropathy. The investigators examined the efficacy and safety
of the treatment algorithm for 64 patients with colorectal cancer by evaluating the side
effects and degree of improvement of subjective symptoms.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jiangsu Province Hospital of Traditional Chinese Medicine